Medicare Enrolled

Dr. Jane Mayrin, MD

Endocrinology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
9880 BUSTLETON AVE, Philadelphia, PA 19115
2158271500
In practice since 2007 (19 years)
NPI: 1467679738 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mayrin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mayrin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mayrin

Dr. Jane Mayrin is an endocrinology specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mayrin performed 3,199 Medicare services across 1,395 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mayrin received a total of $765,572 from 64 pharmaceutical and/or device companies across 1841 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mayrin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in PA $765,572 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,199
Medicare services
Top 11% in PA for endocrinology
1,395
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,289 $94 $245
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,055 $65 $147
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
393 $11 $65
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
185 $27 $103
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
80 $116 $366
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
65 $106 $287
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
63 $63 $176
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
42 $142 $350
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
16 $18 $61
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
11 $136 $331
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$765,572
Total received (2018-2024)
Avg $109,367/year across 7 years
Top 1% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
1,841
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$754,500 (98.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,071 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28,739
2023
$43,027
2022
$85,238
2021
$88,325
2020
$124,006
2019
$213,074
2018
$183,163

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$18,270
Novo Nordisk Inc
$7,616
Corcept Therapeutics
$410
AIMMUNE THERAPEUTICS, INC.
$253
Amgen Inc.
$245
Radius Health, Inc.
$240
Boehringer Ingelheim Pharmaceuticals, Inc.
$223
Medtronic, Inc.
$183
Bayer Healthcare Pharmaceuticals Inc.
$165
Xeris Pharmaceuticals, Inc.
$126
AstraZeneca Pharmaceuticals LP
$116
ABBVIE INC.
$104
Amphastar Pharmaceuticals, Inc.
$76
SANOFI-AVENTIS U.S. LLC
$71
Esperion Therapeutics, Inc.
$68
Astellas Pharma US Inc
$64
Dexcom, Inc.
$59
Antares Pharma, Inc.
$57
Mannkind Corporation
$51
BETA BIONICS, INC.
$50
Novartis Pharmaceuticals Corporation
$47
Abbott Laboratories
$47
Chiesi USA, Inc.
$45
Kyowa Kirin, Inc.
$43
RECORDATI_RARE_DISEASES_INC.
$37
Tandem Diabetes Care, Inc.
$24
Insulet Corporation
$20
SANOFI US SERVICES INC.
$14
Tolmar, Inc.
$13
Top 3 companies account for 91.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$294,992
Novo Nordisk Inc
$201,330
AstraZeneca Pharmaceuticals LP
$94,892
SANOFI-AVENTIS U.S. LLC
$75,086
Amarin Pharma Inc.
$55,223
Janssen Pharmaceuticals, Inc
$26,822
Medtronic, Inc.
$4,580
Intuity Medical Inc
$2,351
Amgen Inc.
$839
Corcept Therapeutics
$805
AbbVie, Inc.
$793
Xeris Pharmaceuticals, Inc.
$745
Boehringer Ingelheim Pharmaceuticals, Inc.
$722
Radius Health, Inc.
$649
Amneal Pharmaceuticals LLC
$516
Mannkind Corporation
$514
Novartis Pharmaceuticals Corporation
$476
Bayer Healthcare Pharmaceuticals Inc.
$407
Becton, Dickinson and Company
$329
Bayer HealthCare Pharmaceuticals Inc.
$270
Antares Pharma, Inc.
$255
AIMMUNE THERAPEUTICS, INC.
$253
MannKind Corporation
$234
Dexcom, Inc.
$229
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$207
NESTLE HEALTHCARE NUTRITION INC.
$199
AbbVie Inc.
$127
ABBVIE INC.
$104
BOSTON SCIENTIFIC CORPORATION
$102
Alexion Pharmaceuticals, Inc.
$102
Embecta Corp.
$96
Clarus Therapeutics Inc.
$80
Tandem Diabetes Care, Inc.
$78
Amphastar Pharmaceuticals, Inc.
$76
Esperion Therapeutics, Inc.
$68
Abbott Laboratories
$67
Tolmar, Inc.
$65
Astellas Pharma US Inc
$64
Kyowa Kirin, Inc.
$62
Supernus Pharmaceuticals, Inc.
$61
Insulet Corporation
$59
Ultragenyx Pharmaceutical Inc.
$57
BETA BIONICS, INC.
$50
PFIZER INC.
$46
Chiesi USA, Inc.
$45
VIVUS LLC
$42
RECORDATI_RARE_DISEASES_INC.
$37
Senseonics, Incorporated
$36
Horizon Therapeutics plc
$36
Averitas Pharma Inc.
$33
Endo Pharmaceuticals Inc.
$29
OPKO Pharmaceuticals, LLC
$29
Ascendis Pharma Inc
$28
Acerus Pharmaceuticals Corporation
$23
Ipsen Biopharmaceuticals, Inc
$18
Medtronic MiniMed, Inc.
$17
Zealand Pharma US, Inc.
$16
Gemini Laboratories, LLC
$15
GRT US Holding, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Companion Medical, Inc.
$15
SANOFI US SERVICES INC.
$14
Kowa Pharmaceuticals America, Inc.
$13
Nestle HealthCare Nutrition Inc.
$12
Top 3 companies account for 77.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CREON · CYCLOSET · Creon · Crysvita · Cryvista · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LOKELMA · LYNPARZA · LYUMJEV · Livalo · MINIMED 630G · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 770G System · NASCOBAL · NEXLETOL · NOCDURNA · Natesto · Omnipod · Ozempic · Pogo Automatic Blood Glucose Monitoring System · QUTENZA · Qsymia · Qutenza · RAYALDEE · RECORLEV · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Saxenda · Strensiq · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Veozah · Victoza · WATCHMAN · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in PA.

Looking for an endocrinology specialist in Philadelphia?
Compare endocrinologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
207
Per 100K population
13.1
County median income
$60,698
Nearest hospital
NAZARETH HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mayrin is a clinical cardiology specialist, with above-average Medicare volume (top 11% in PA), with speaking/promotional industry engagement in the top 1% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mayrin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mayrin performed 1,289 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mayrin receive payments from pharmaceutical companies?
Yes. Dr. Mayrin received a total of $765,572 from 64 companies across 1,841 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mayrin's costs compare to other endocrinologists in Philadelphia?
Dr. Mayrin's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mayrin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →